| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $13.4M | -27.0% | -24.3% |
| SG&A Expense | $5.2M | -5.6% | -4.0% |
| Operating Income | -$18.7M | +22.1% | +19.5% |
| Pre-tax Income | -$18.0M | +21.9% | +15.7% |
| Income Tax | $0 | — | — |
| Net Income | -$18.0M | +21.9% | +15.7% |
| EPS (Basic) | -$0.52 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $142.8M | +307.1% | +237.6% |
| Short-term Investments | $20.9M | -47.2% | -78.4% |
| Current Assets | $166.2M | +114.5% | +16.7% |
| Total Assets | $190.1M | +85.9% | +11.6% |
| Current Liabilities | $12.6M | -22.7% | -24.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$65.8M | — | — |
| Capital Expenditures | $265K | — | — |
| Investing Cash Flow | $51.0M | — | — |
| Financing Cash Flow | $108.2M | — | — |
| Free Cash Flow | -$66.1M | — | — |
| +21.2% |
| EPS (Diluted) | -$0.52 | +25.7% | +21.2% |
| $26.9M |
| -13.4% |
| -17.9% |
| Stockholders' Equity | $163.1M | +129.3% | +18.7% |